LRRK2 and Parkinson disease: Expression of IFN‐γ in neonatal LRRK2 G2019S knock‐in mice67 led to increased tau phosphorylation on specific epitopes in the cortex and midbrain, potentially explaining why some LRRK2 G2019S PD patients present with tau pathology.